Priapism Risk with Zyrtec and Norvasc
Neither cetirizine (Zyrtec) nor amlodipine (Norvasc) are established causes of priapism, and priapism is not listed as an adverse effect in the FDA labeling for amlodipine. However, there is emerging case report evidence linking structurally-related antihistamines to priapism through alpha-adrenergic antagonism.
Amlodipine (Norvasc) and Priapism
The FDA drug label for amlodipine does not list priapism among its adverse reactions, even in the comprehensive listing of events occurring in <1% of patients 1. The most common adverse effects are peripheral edema, dizziness, flushing, and palpitations—none related to erectile function abnormalities.
Sexual Function Data
- In the Treatment of Mild Hypertension Study (TOMHS), amlodipine showed no increased incidence of erectile dysfunction compared to placebo over 48 months of follow-up 2
- The incidence of erection problems with amlodipine (similar to placebo) was significantly lower than with chlorthalidone
- Amlodipine does not appear to cause priapism through its calcium channel blocking mechanism
Clinical Bottom Line for Amlodipine: This medication is not associated with priapism and can be safely continued if a patient develops priapism from another cause.
Cetirizine (Zyrtec) and Priapism
Cetirizine itself has no documented association with priapism in the medical literature. However, hydroxyzine (a structurally-related first-generation antihistamine) has been implicated in a case report of priapism when added to risperidone 3.
Mechanism of Concern
- Hydroxyzine possesses alpha-adrenergic antagonism activity in addition to antihistamine effects
- Alpha-1 blockade can impair detumescence by preventing smooth muscle contraction in the corpora cavernosa
- A 35-year-old male stable on risperidone developed priapism requiring phenylephrine injection after 10 days of hydroxyzine 50 mg nightly 3
Key Distinction
- Cetirizine is a second-generation antihistamine with minimal alpha-adrenergic activity
- Unlike hydroxyzine, cetirizine is highly selective for H1 receptors and does not significantly cross the blood-brain barrier
- No case reports link cetirizine specifically to priapism
Clinical Bottom Line for Cetirizine: While theoretically possible through class effects, there is no documented evidence of cetirizine causing priapism. The risk appears negligible compared to first-generation antihistamines like hydroxyzine.
Clinical Approach
If a patient on either medication develops priapism:
Immediate management follows standard priapism protocols—intracavernosal phenylephrine is first-line for ischemic priapism <4 hours 4
Medication review should focus on:
- Antipsychotics (especially risperidone, quetiapine)
- Alpha-blockers (prazosin, doxazosin, terazosin)
- Trazodone
- Intracavernosal injection therapy
- First-generation antihistamines (hydroxyzine, diphenhydramine)
Do not discontinue amlodipine or cetirizine based solely on priapism occurrence—look for more likely culprits first
If hydroxyzine is being used (not cetirizine), consider this a potential contributor, especially if combined with antipsychotics 3
Important Caveats
- The absence of priapism in FDA labeling and large clinical trials strongly argues against amlodipine as a causative agent
- Cetirizine's pharmacologic profile makes priapism highly unlikely
- Always consider sickle cell disease, hematologic disorders, and penile trauma as non-pharmacologic causes
- Multiple medication interactions may increase risk (e.g., hydroxyzine + antipsychotics) even when individual agents are low-risk 3